Cyclosporin-A acts on:
Wait, the question is asking what Cyclosporin acts on. The options are A-D, but they're not provided. The correct answer is probably related to calcineurin. Cyclosporin binds to cyclophilin, forming a complex that inhibits calcineurin, which is a phosphatase. This prevents the dephosphorylation of NFAT, so transcription of IL-2 doesn't occur. So, T-cell activation is blocked.
Now, the wrong options might include other enzymes or receptors. For example, maybe they list cyclophilin as an option, which is the binding site but not the actual target. Or perhaps other phosphatases like protein phosphatase 1 or 2A. Another possible incorrect option could be something like kinases, since some immunosuppressants like FK506 also inhibit calcineurin but the mechanism is similar. Or maybe they list a receptor like the IL-2 receptor, which is downstream.
The clinical pearl is that Cyclosporin and Tacrolimus both inhibit calcineurin but through different binding proteins (cyclophilin vs FKBP). Students often confuse them. Also, adverse effects like nephrotoxicity are important to remember.
I need to structure the explanation with the required sections. For the Core Concept, state that Cyclosporin inhibits calcineurin. Then explain the mechanism in the correct answer section. For the wrong options, if they include cyclophilin, explain that it's the binding site, not the target. If there's a kinase, mention that Cyclosporin acts on a phosphatase. For the clinical pearl, highlight the calcineurin inhibition and the difference from Tacrolimus.
**Core Concept**
Cyclosporin-A is an immunosuppressive drug that inhibits **calcineurin**, a calcium-dependent serine/threonine phosphatase critical for T-cell activation. Its mechanism involves binding to **cyclophilin**, forming a complex that blocks calcineurin, preventing dephosphorylation of the transcription factor **nuclear factor of activated T-cells (NFAT)** and subsequent IL-2 production.
**Why the Correct Answer is Right**
Cyclosporin-A specifically targets **calcineurin** in T-cells. By inhibiting this phosphatase, it prevents the dephosphorylation of NFAT, which is required for its translocation to the nucleus. Without NFAT activation, transcription of **interleukin-2 (IL-2)** is blocked, halting T-cell proliferation and immune response. This makes calcineurin the *direct pharmacologic target*, distinguishing Cyclosporin from other immunosuppressants like rapamycin (which targets mTOR).
**Why Each Wrong Option is Incorrect**
**Option A:** *Cyclophilin